The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Meta's newest AI model beats some peers. But its amped
China's 40th Antarctic Scientific Expedition Begins
World Children's Day Celebrated with Light Shows Across China
Bills would preferably be on the receiving end in the NFL draft after dealing Diggs to Houston
World 5G Convention Kicks off in Zhengzhou, C China's Henan
(COP28) Climate Summit Launches Partnership to Promote Women's Climate Resilience
Rural Tourism Route Injects New Momentum into Countryside in SW China's Chongqing
Kenya’s military chief dies in a helicopter crash
Palestinian death toll from Israeli attacks on Gaza rises to 32,226
Caitlin Clark fans won't receive Indiana Fever jerseys until August due to Nike blunder
Commission, Departments Help Children Improve Mental Well